REGENERON PHARMACEUTICALS, INC.: revenue

Value{"amount": 6710800000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"}
Period2018-01-01 – 2018-12-31
Statussuperseded
EntityREGENERON PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001532176-19-000009
Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000872589/revenue/2018-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/bc79cb58-0f5a-4fd0-a01f-389bc9e23296

History